MedTrace Logo

Analysis by Clinical Mass Spectrometry of Bloodstains

NCT02896634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2019-08-07

No results posted yet for this study

Summary

Dried Blood Spot or DBS is a collection of blood capillary drops spotted and dried on to a filter paper used for different bioanalysis. In comparison to conventional blood testing, DBS offers practical, analytical, clinical and financial advantages. This less invasive sampling is already used in infectious diseases screening and is useful for persons with poor venous (babies, drug users or elderly). Mass-spectrometry-based analyses allow protein quantification on very low amount of blood sample. In the project we combine the two approaches to measure on DBS blood proteins with clinical relevance -including many FDA approves biomarkers). The detection of the relevant clinical analytes will be validated on available patient samples in accordance with the clinical norm ISO15189 and the requirement for CE IVD marking. This will allow commercial developments (kits, protocols...) realized with the industrial partner Spot-to-lab

Conditions

  • Patient Blood Biobank

Interventions

BIOLOGICAL

clinical biology analyzes spectrometry mass

clinical biology analyzes spectrometry mass

Sponsors & Collaborators

  • SPOT-TO-LAB Montpellier

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Sylvain Lehmann, PH PU · UHMONTPLLIER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2017-03-01
Completion
2018-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02896634 on ClinicalTrials.gov